(Q39837248)

English

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation (English)

1 reference

Europe PubMed Central

15 September 2017

0 references

3

1 reference

Europe PubMed Central

15 September 2017

4

1 reference

Europe PubMed Central

15 September 2017

object named as

U Reichl

6

0 references

author name string

V Lohr

1

1 reference

Europe PubMed Central

15 September 2017

A Rath

2

1 reference

Europe PubMed Central

15 September 2017

V Sandig

5

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

14 June 2009

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

27

1 reference

Europe PubMed Central

15 September 2017

36

1 reference

Europe PubMed Central

15 September 2017

4975-4982

1 reference

Europe PubMed Central

15 September 2017

describes a project that uses

0 references

0 references

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Production of influenza virus in cell cultures for vaccine preparation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Identification and characterization of avian retroviruses in chicken embryo-derived yellow fever vaccines: investigation of transmission to vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

An avian cell line designed for production of highly attenuated viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Pyruvate secreted by human lymphoid cell lines protects cells from hydrogen peroxide mediated cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Characterization of changes in PER.C6 cellular metabolism during growth and propagation of a replication-deficient adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Evaluation of the new serum-free medium (MDSS2) for the production of different biologicals: use of various cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Cultivation of recombinant Chinese hamster ovary cells grown as suspended aggregates in stirred vessels.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

The longest micron; transporting poxviruses out of the cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

The formation and function of extracellular enveloped vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

The cellular inhibitor of the PKR protein kinase, P58(IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Current Status for High Titre Poxvirus Stock Preparation in CEF Under Serum-Free Medium Conditions: Implication for Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Comparison of virus production in chicken embryo fibroblasts infected with the WR, IHD-J and MVA strains of vaccinia virus: IHD-J is most efficient in trans-Golgi network wrapping and extracellular enveloped virus release

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 1. Analysis of data from controlled batch reactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.083

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.05.083

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39837248&oldid=2091242958"